Triller Inc. recebe US $ 310 milhões em fundos de participação acionária da Global Emerging Markets (GEM) em conexão com a sua abertura de capital

A empresa espera ser negociada publicamente no início do 4º trimestre sob o símbolo “ILLR”

LOS ANGELES, Sept. 30, 2022 (GLOBE NEWSWIRE) — A Triller Inc.(“Triller”) e a GEM Global Yield LLC SCS (“GGY”) anunciaram hoje um investimento vinculativo de US $ 310 milhões da GEM, grupo de investimento alternativo privado sediado em Luxemburgo, na forma de participação acionária. Sob com o acordo, a GEM fornecerá à Triller até US $ 310 milhões em capital acionário durante o período de 36 meses após a colocação pública das ações ordinárias da Triller.

A Triller não será obrigada a sacar todos os US $ 310 milhões, somente parte ou todo, como decidir. A Triller irá determinar a ocasião e o valor de todos os desembolsos e emitirá ações para a GEM em cada desembolso do programa. A Triller também irá emitir warrants para a GEM, alinhando ainda mais os interesses das empresas.

A Triller registrou seu S-1 privado na Comissão de Valores Mobiliários dos EUA no mês passado e está enviando o que espera ser o S-1 final simultaneamente com o fechamento do programa. A expectativa é que a negociação tenha início do quarto trimestre de 2022.

“A Triller tem crescido exponencialmente”, disse Mahi de Silva, CEO e Presidente da Triller. “No início, em 2019, éramos uma empresa de receita zero; agora estamos no caminho certo para ultrapassar US $ 100 milhões de receita este ano. O aplicativo Triller foi baixado mais de 350 milhões de vezes, e a empresa trabalha com dezenas das maiores marcas do mundo e milhares de artistas famosos, causando uma disrupção criativa.”

A Triller tem 10 linhas de negócios, oito das quais estão no ponto de equilíbrio ou são lucrativas, com 750 milhões de interações por trimestre, cada uma sendo uma potencial transação monetizável para a empresa no futuro.

Com a infusão de capital da GEM, a Triller poderá fazer outras aquisições para fortalecer sua caixa de ferramentas para a comunidade de criadores e alcançar o ponto de equilíbrio ou lucratividade no curto prazo. Com a linha de crédito de US $ 310 milhões, a Triller terá arrecadado mais de US $ 600 milhões de dólares e, após a abertura do capital, estará praticamente livre de dívidas.

“A Triller está quebrando todas as regras dos sistemas de plataformas fechadas. É incrível como o sistema tradicional se aproveita dos criadores e usuários, mantendo 99% do dinheiro do sistema”, disse De Silva. “O motivo pelo qual a indústria está tão focada nas métricas MAU/DAU e outras do gênero é que o tempo que alguém passa dentro de uma plataforma fechada de uma empresa significa que as redes sociais são ‘donas’ do usuário, receita, marca e informações.

“O Triller rompe esse sistema. Com a nossa plataforma aberta devolvemos o controle para os criadores e usuários, permitindo a conexão direta dos criadores com as marcas. Fornecemos ferramentas para maximizar as conexões e a qualidade da sua monetização. Além disso, a análise do número de interações nos ajuda a prever receitas futuras, pois cada uma delas pode resultar em uma taxa de transação para nós.”

Sobre a Triller Inc.

Triller é uma plataforma com tecnologia Open Garden alimentada por IA para criadores de conteúdo. Com a união da cultura musical com esportes, moda, entretenimento e influenciadores, por meio de uma visão de 360 graus do conteúdo e da tecnologia, a Triller incentiva seus influenciadores a postar o conteúdo criado no aplicativo em diferentes plataformas de redes sociais, utilizando sua tecnologia de IA para impulsionar e rastrear seu conteúdo de forma viral em sites e redes afiliadas e não afiliadas, permitindo que alcancem milhões de usuários adicionais. Além disso, a Triller é proprietária da VERZUZ, plataforma de live-stream de música; marcas de esportes de combate Triller Fight Club, Triad Combat e BKFC; Amplify.ai, plataforma líder em engajamento com clientes; FITE.tv, serviço global premier de streaming PPV, AVOD e SVOD; Thuzio, líder em eventos e experiências de influenciadores premium B2B; Fangage, plataforma para criadores para engajamento com fãs e monetização de conteúdo, e Julius, plataforma para marcas e agências para utilização de criadores para engajamento e comércio social.

Sobre a GEM
Global Emerging Markets (“GEM”) é um grupo de investimento alternativo privado de US $ 3,4 bilhões, com sede em Luxemburgo e com escritórios em Paris, Nova York e Bahamas. A GEM administra um conjunto diversificado de veículos de investimento focados em mercados emergentes, com mais de 530 transações fechadas em mais de 70 países. Cada veículo de investimento tem um nível diferente de controle operacional, retorno ajustado ao risco e perfil de liquidez. A família de fundos e veículos de investimento fornecem à GEM e seus parceiros exposição a: Management Buyouts de empresas de pequeno e médio porte, Investimentos Privados em Ações Públicas e investimentos em certos empreendimentos. Para mais informações: http://www.gemny.com

Tony Freinberg
Presidente, Edendale Strategies
tony@edendalestrategies.com
(310) 614-1435

Triller Inc. obtient un financement en capital de 310 millions de dollars de la part de Global Emerging Markets (GEM) dans le cadre de son introduction en bourse à venir

La société prévoit d’être cotée en bourse au début du 4e trimestre sous le symbole « ILLR »

LOS ANGELES, 30 sept. 2022 (GLOBE NEWSWIRE) — Triller Inc. (« Triller ») et GEM Global Yield LLC SCS (« GGY ») ont annoncé aujourd’hui un investissement contraignant de 310 millions de dollars de la part de GEM, le groupe d’investissement alternatif privé basé au Luxembourg, sous la forme d’une facilité de souscription d’actions. En vertu de cet accord, GEM fournira à Triller jusqu’à 310 millions de dollars de capitaux propres sur une durée de 36 mois suite à l’introduction en bourse des actions ordinaires de Triller.

Triller ne sera pas tenue d’utiliser l’intégralité des 310 millions de dollars, mais pourra le faire en partie ou en totalité à sa discrétion. Triller contrôlera à la fois le calendrier et le montant de tous les prélèvements et émettra des actions à GEM pour chaque montant prélevé de la facilité. Triller émettra également des bons de souscription à GEM, alignant davantage les intérêts des sociétés.

Triller a déposé son formulaire S-1 privé auprès de la Securities and Exchange Commission des États-Unis le mois dernier et soumet ce qu’elle prévoit d’être le dernier formulaire S-1 parallèlement à la clôture de cette facilité. La société prévoit de commencer à être cotée en bourse au début du 4e trimestre 2022.

« Triller connaît une croissance considérable », a déclaré Mahi de Silva, PDG et président de Triller. « Lors de notre création en 2019, nous étions une société à chiffre d’affaires nul et nous sommes maintenant en bonne voie pour générer 100 millions de dollars de chiffre d’affaires cette année. L’application Triller a été téléchargée plus de 350 millions de fois, et la société travaille avec des dizaines des plus grandes marques au monde et des milliers d’artistes de premier plan, perturbant l’ensemble de la communauté des créateurs. »

Triller compte 10 branches d’activité, dont huit sont sont au seuil de rentabilité ou rentables, et effectue 750 millions d’interactions par trimestre, chacune étant une transaction potentiellement monétisable pour la société à l’avenir.

Avec l’infusion de capital de GEM, Triller sera en mesure de réaliser des acquisitions supplémentaires pour renforcer sa boîte à outils pour la communauté des créateurs et atteindre le seuil de rentabilité ou la rentabilité à court terme. En supposant qu’elle utilise la totalité de la facilité d’investissement de 310 millions de dollars, Triller aura levé plus de 600 millions de dollars et, au moment de son introduction en bourse, sera pratiquement exempte de dette.

« Triller enfreint toutes les règles des systèmes de jardin fermé. Cela remet en question la façon dont la vieille garde tire parti des créateurs et des utilisateurs en conservant pour elle 99 % de l’argent au sein du système », a ajouté M. De Silva. « La raison pour laquelle le secteur est axé sur le nombre d’utilisateurs actifs mensuels, quotidiens ou autre est parce que cela représente le temps qu’une personne passe dans le jardin fermé particulier d’une entreprise et cela signifie que les réseaux sociaux “possèdent” l’utilisateur, les revenus, la marque et les informations. »

« Triller brise totalement ce système. En tant que jardin ouvert, notre objectif est de redonner le pouvoir aux créateurs et aux utilisateurs, en permettant aux créateurs et aux marques de se connecter directement. Nous fournissons des outils qui permettent de maximiser ces connexions et la façon font chacune d’elles peut être monétisée. En outre, prendre en considération le nombre d’interactions que nous facilitons nous aide à prévoir les revenus futurs puisque chacune d’elles représente des frais de transaction potentiels pour nous. »

À propos de Triller Inc.

Triller est la plateforme technologique de « jardin ouvert » alimentée par l’IA pour les créateurs. En associant la culture musicale au sport, à la mode, au divertissement et aux influenceurs par le biais d’une vision à 360 degrés du contenu et de la technologie, Triller encourage ses influenceurs à publier le contenu créé sur l’application à travers différentes plateformes de réseaux sociaux et utilise une technologie exclusive d’IA pour promouvoir et suivre leur contenu de manière virale sur des sites et réseaux affiliés et non affiliés, leur permettant d’atteindre des millions d’utilisateurs supplémentaires. Triller possède également VERZUZ, la plateforme de musique en direct, les marques de sport de combat Triller Fight Club, Triad Combat et BKFC, Amplify.ai, une plateforme d’engagement client de premier plan, FITE.tv, un service de streaming PPV, AVOD et SVOD mondial de premier plan, Thuzio, un leader dans les événements et expériences d’influenceurs B2B de qualité supérieure, Fangage, une plateforme permettant aux créateurs de s’engager avec les fans et de monétiser le contenu, et Julius, une plateforme permettant aux marques et aux agences de tirer parti des créateurs pour l’engagement social et le commerce social.

À propos de GEM
Global Emerging Markets (« GEM ») est un groupe privé d’investissement alternatif de 3,4 milliards de dollars, basé au Luxembourg, avec des bureaux à Paris, à New York et aux Bahamas. GEM gère un ensemble diversifié de véhicules d’investissement axés sur les marchés émergents et a réalisé plus de 530 transactions dans plus de 70 pays. Chaque véhicule d’investissement possède un degré différent de contrôle opérationnel, de rendement ajusté au risque et de profil de liquidité. Cette famille de fonds et de véhicules d’investissement fournit à GEM et à ses partenaires une exposition à des rachats d’entreprise de petites et moyennes capitalisations, des investissements privés dans des actions publiques et des investissements de capital-risque sélectionnés. Pour tout complément d’information : http://www.gemny.com

Tony Freinberg
Président d'Edendale Strategies
tony@edendalestrategies.com
(310) 614-1435

Madison Newbond Hotel Lending Platform Originates $20 Million Loan for the Balfour Hotel in Miami Beach

NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Madison Newbond, the institutional lending platform of Madison Realty Capital and Newbond Holdings that provides first mortgages, mezzanine loans and preferred equity to hotel owners and developers nationwide, today announced that it has provided a $20 million loan to FullG Capital’s equity sponsorship group for the acquisition of the Balfour Hotel Miami Beach (the “Balfour”), an independent boutique hotel located at 350 Ocean Drive in Miami Beach, Florida.

Located within Miami’s famed South Beach Art Deco District and situated less than one block from the beach, the Balfour contains 82 guestrooms across two towers, as well as an upscale restaurant and bar, an outdoor plunge pool, complimentary beach services, and approximately 1,300 square feet of rooftop terrace space. The hotel is managed by Driftwood Hospitality Management under a third-party hotel management agreement.

Josh Zegen, Managing Principal and Co-Founder of Madison Realty Capital, said, “Miami is no longer just a top destination for domestic and international leisure travel, but has rapidly become a growing hub for corporations and financial firms seeking to relocate their headquarters. We are pleased to provide a flexible financing solution to facilitate the acquisition of a superbly well-located hotel in one of the most liquid and dynamic hospitality markets in the country.”

Drew Coles, President of FullG Capital said, “Madison Realty Capital is a highly experienced lender in the Miami hospitality market with a reputation for certainty of execution. We are thrilled to leverage Madison Newbond’s attractive financing capabilities to complete the acquisition of the Balfour.”

Neil Luthra, Founding Partner at Newbond, added, “Madison and Newbond’s extensive operating experience enables us to efficiently underwrite hospitality lending opportunities and provide borrowers with a reliable financing partner in today’s choppy credit environment.  The Balfour perfectly exemplifies this, and we are excited to work with the FullG Capital team to bring their business plan to life.”

Madison Realty Capital has significant experience investing in hotel and luxury condominium developments in Miami and across South Florida. Notable transactions include an $85 million loan to The Related Group, BH Group, Teddy Sagi’s Globe Invest, and Wanxiang Group Corporation for the acquisition and pre-development of a luxury condominium project on Fisher Island in Miami Beach, a $76 million loan to The Related Group for the development of District 225, a 343-unit luxury condominium project in Miami, a $210 million loan to Fort Partners for the construction of the Four Seasons Hotel and Private Residences Fort Lauderdale, and a $105 million loan to Fort Partners for the acquisition and modernization of the Four Seasons Hotel Miami.

Madison Newbond launched in November 2021 with approximately $500 million of initial lending capacity and has plans to add scale in line with existing opportunities.

 

About Madison Realty Capital 

Madison Realty Capital is a vertically integrated real estate private equity firm that, as of August 31, 2022, manages approximately $9.5 billion in total assets on behalf of a global institutional investor base. Since 2004, Madison Realty Capital has completed approximately $21 billion in transactions providing borrowers with flexible and highly customized financing solutions, strong underwriting capabilities, and certainty of execution. Headquartered in New York City, with an office in Los Angeles, the firm has approximately 70 employees across all real estate investment, development, and property management disciplines. Madison Realty Capital has been named to Commercial Observer’s prestigious “Power 100” list of New York City real estate players. To learn more, follow us on LinkedIn and visit www.madisonrealtycapital.com.

About Newbond Holdings

Newbond Holdings, founded by Neil Luthra and Vann Avedisian in 2021, is a real estate investment and operating platform focused on debt and equity investments across multiple real estate product types with a hospitality focus as well as investments in related operating businesses and technology platforms. The partners at Newbond have completed over $15 billion of debt and equity transactions. As a vertically integrated operating and investment platform, Newbond is uniquely positioned to create significant value beyond the typical investment process through creative structuring, operations and the development of single and multiple asset brands.

Nathaniel Garnick/Grace Cartwright
Gasthalter & Co.
(212) 257-4170
madisonrealty@gasthalter.com

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

World’s Only Robotic Radiation Therapy Device Delivers Extremely Precise Treatments in Just 1 to 5 Out-Patient Sessions

SUNNYVALE, Calif., Sept. 30, 2022 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform in Africa, making it possible for more patients to obtain access to the extremely precise stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments the system delivers. The Children’s Cancer Hospital 57357 (Hospital 57357) medical care team is the first in Egypt and Africa to treat patients using the system, while the Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) is the second in Africa and first in Kenya to acquire the system.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

The number of new cancer cases diagnosed annually in Egypt and Kenya is anticipated to increase by approximately 75% and 126%, respectively, between 2020 and 20401. Innovative treatment options – such as the CyberKnife platform – can effectively treat certain neurologic conditions and a wide range of tumor types throughout the body, and at various stages of disease, while minimizing the impact of the treatment on a patient’s life.

“Our partnerships with the Children’s Cancer Hospital 57357 and Kenyatta University Teaching, Referral & Research Hospital teams directly aligns with our vision, and their goal, to expand all patient access to the most advanced radiation therapy treatments and to improve healthcare equity in areas where historically these treatments have not been an option,” said Suzanne Winter, president and CEO of Accuray. “We are proud that such esteemed organizations have selected the CyberKnife System to enhance the quality of care they provide their patients. The system will provide them with the tools they need to offer more patients extremely precise, powerful treatments that enable them to get back to living their lives, faster.”

The entire CyberKnife procedure is typically completed in just 1 to 5 out-patient sessions, providing a shorter overall course of treatment compared to conventional radiation therapy which typically takes 30-40 sessions. The condensed treatment schedule causes less disruption of patients’ daily lives and enables those people who are unable to travel a month or more for care to receive radiation therapy treatments delivered with sub-millimeter precision and accuracy.

Improving Patient Outcomes in Egypt
Hospital 57357 continues its legacy of innovation with the installation and treatment of the first patients in Egypt and Africa using the CyberKnife System. The radiation treatment delivered with the system is a non-invasive, non-surgical, typically pain-free outpatient procedure that does not require incisions or general anesthesia. Most patients will not require hospitalization or experience a long recovery period following the treatment procedure.

“At Children’s Cancer Hospital 57357, patients and their families are at the center of everything we do. We are proud to be the first hospital in Egypt and Africa to offer our patients treatment with the CyberKnife System, an innovative radiation therapy delivery technology we believe will enable us to improve patients’ outcomes and increase overall survival rates,” said Mohamed Saad Zaghloul, M.D., head of the radiation oncology department, Children’s Cancer Hospital 57357. “The system is designed to treat tumors throughout the body and provides us with an alternative to surgery for patients who have inoperable or surgically complex tumours, expanding the number of patients we can help.”

Dr. Zaghloul continued, “Importantly, we can decrease the number of radiation sessions needed to between 1 and 5, without sacrificing the precision of the treatment we deliver. This is a significant benefit for our patients who want to be able to get back to spending time with their families and participating in the daily activities that other children their age enjoy.”

Expanding Access to Advanced Cancer Care in Kenya
KUTRRH is a leading Public National Referral Hospital dedicated to enhancing the health and well-being of Kenyans and global citizens through provision of patient-centered and evidence-based healthcare. The CyberKnife® System will provide their team with the tools they need to provide optimal treatments for people diagnosed with cancer, benign tumors or certain neurologic disorders. The system was designed to provide clinicians with the speed required for workflow efficiency and the ability to deliver treatments more quickly – in as little as 15 minutes – while maintaining the precision and accuracy required for SRS and SBRT.

“In Kenya, cancer is a public health concern and too few people who would benefit from radiation therapy treatments are receiving care. For our region and our country, we believe the CyberKnife System will revolutionize cancer care,” said Prof. Olive Mugenda Ph.D., MGH Chairperson, Kenyatta University Teaching, Referral & Research Hospital.

Continued Prof. Mugenda, “The Cyberknife System has been one of the reason Kenyans have been travelling abroad for treatment. Having this system in Kenya, will not only improve the quality of life but also reverse outbound medical tourism.”

Jos. Hansen (East Africa) Ltd. is a leading distributor of trusted and reliable healthcare equipment and is the exclusive partner for the Accuray CyberKnife and TomoTherapy® platforms, including the next-generation Radixact® System, in Kenya. Jos. Hansen has a long-term relationship with the KUTRRH team and consulted with them as they evaluated radiation therapy devices and selected the CyberKnife S7™ System.

Important Safety Information
For Important Safety Information please refer to https://www.accuray.com/safety-statement.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.

Safe Harbor Statement
Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to clinical applications, clinical results, patient experiences and patient outcomes. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of the company’s assumptions prove incorrect, actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the company’s ability to achieve widespread market acceptance of its products, including new product innovations and releases; the company’s ability to develop new products or improve existing products to meet customers’ needs; the company’s ability to anticipate or keep pace with changes in the marketplace and the direction of technological innovation and customer demands; and such other risks identified under the heading “Risk Factors” in the company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on August 17, 2022, and as updated periodically with the company’s other filings with the SEC.

Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.

Media Contact:
Beth Kaplan                                                      
Public Relations Director, Accuray                       
+1 (408) 789-4426
bkaplan@accuray.com

1 https://gco.iarc.fr/tomorrow/en/dataviz/tables?populations=404_818&years=2040 

Logo – https://mma.prnewswire.com/media/320376/accuray_incorporated_logo.jpg

Cholera Surging Globally as Climate Change Intensifies

Cholera is surging around the globe, the World Health Organization warns.

Flareups of the deadly disease have been reported in 26 countries in the first nine months of this year. In comparison, fewer than 20 countries reported cholera outbreaks per year between 2017 and 2021. In addition to greater frequency, the WHO reports the outbreaks themselves are larger and more deadly.

While poverty and conflict are major triggers of cholera, climate change is a growing threat.

Philippe Barboza, WHO team lead for Cholera and Epidemic Diarrheal Diseases, said climate change presents an additional layer of complexity and creates the conditions for cholera outbreaks to explode.

“This is what we have seen in southern Africa with the succession of cyclones that affected the eastern part of the African Coast,” Barboza said. “The drought in East Africa is driving population movements, reducing access to water, which is already needed. So, of course, it is a key factor, which is fueling the outbreak. And the same in Sahel and other places.”

Fifteen of the 26 cholera-infected countries are in Africa, according to the WHO.

Barboza said massive climate-induced floods in Southeast Asia also have resulted in large outbreaks of cholera in Pakistan and Bangladesh. Many countries that have made significant progress in controlling cholera are now back to square one, he added.

Cholera is an acute diarrheal disease caused by contaminated food or water. It can kill within hours if left untreated. Cholera outbreaks can be prevented by ensuring access to clean water, basic sanitation, and hygiene, as well as stepping up surveillance and access to health care, Barboza said.

“This is what we need countries to do, but that is easier said than done. Although many of the cholera-affected countries are actively engaged in these efforts, they are facing multiple crises, including conflict and poverty, and this is why international action is so important,” he said.

Cholera is a preventable and treatable disease, Barboza said, so with the right foresight and action, the current global crisis can be reversed.

Source: Voice of America

UN Report Targets Racism Against People of African Descent

A report by the U.N. human rights office finds systemic racism against people of African descent is deep-rooted and says urgent measures are needed to dismantle discriminatory systems.

It took the death of a Black man, George Floyd, 46, at the hands of a police officer in the United States in May 2020 to draw global attention to the problem of systemic racism. There was a groundswell of global support in the immediate aftermath of the event, which has since largely fizzled out.

The United Nations reports some countries have taken steps to address racism. But those, for the most part, have been piecemeal. They fall short of what is needed to dismantle the entrenched, societal racism that has existed for centuries.

U.N. human rights spokeswoman Ravina Shamdasani says people of African descent in many countries have less access to health, food and education, and they often are victims of enforced disappearance and violence.

She says the U.N. report finds African migrants and migrants of African descent are victims of excessive use of force and killings by law enforcement officials. She says they are subject to punitive drug policies and arrests and are overly represented in prisons.

“Where available, the data continues to point to disproportionately high rates of death of people of African descent by law enforcement in different countries,” Shamdasani said. “And families of African descent continue to report the immense challenges, barriers and protracted processes that they face in their pursuit of truth and justice for the deaths of their relatives.”

The report focuses in detail on seven cases of police-related fatalities of people of African descent. They include the cases of Floyd and Breonna Taylor, an African American medical worker shot and killed by police in March 2020.

Shamdasani said their families are still seeking justice, as are the families of five other people of African descent killed by police agents in France, Brazil, the United Kingdom and Colombia.

“A year later, the report states that while there has been some progress toward accountability in some of these emblematic cases, unfortunately, not a single case has yet been brought to a full conclusion,” she said.

Shamdasani said the Office of the High Commissioner for Human Rights has been mandated by the U.N. Human Rights Council to follow the issue. She said the office would be producing annual reports on progress and on new violations that come to light.

Source: Voice of America